Clinical data have demonstrated that overexpression of RAD6B decreases the sensitivity of rectal cancer cells to ionizing radiation, suggesting that RAD6B is a poor prognostic factor for rectal cancer patients after radiotherapy [28]. Here, UBE2B is linked to rectal cancer.